SCHEMBL30438100

SCHEMBL30438100

c1cc2ncc(N3CCOCC3)cc2[nH]1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SYK P43405 1/20 0.49
POLB P06746 1/20 0.46
PIK3CA P42336 3/20 0.45
PIK3CD O00329 2/20 0.45
PIK3CB P42338 2/20 0.45
PIK3CG P48736 1/20 0.44
AKR1C3 P42330 1/20 0.44
MTOR P42345 1/20 0.44
QPCT Q16769 1/20 0.44
MAP3K12 Q12852 1/20 0.43
JAK2 O60674 1/20 0.43
CNR2 P34972 1/20 0.43
JAK3 P52333 1/20 0.42
TTBK1 Q5TCY1 2/20 0.42
TTBK2 Q6IQ55 2/20 0.42
MAP3K11 Q16584 2/20 0.42
LRRK2 Q5S007 1/20 0.41
MAPT P10636 2/20 0.41
MEN1 O00255 1/20 0.41
NPC1 O15118 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL856151 0.77 PIK3CA (0.51) POLBPIK3CAPIK3CDPIK3CBPIK3CG
SCHEMBL18108512 0.76 PIK3CA (0.63) POLBPIK3CAPIK3CDPIK3CBPIK3CG
SCHEMBL29141989 0.75 AKR1C3 (0.41) POLBPIK3CAPIK3CDPIK3CBAKR1C3
SCHEMBL8600042 0.75 SIGMAR1 (0.48) POLBLMNA
SCHEMBL4243835 0.74 KDM4E (0.48) POLBPIK3CAPIK3CDPIK3CBMTOR
SCHEMBL444108 0.73 GHSR (0.52) PIK3CAPIK3CDPIK3CBPIK3CGMTOR
SCHEMBL2280216 0.73 AKR1C3 (0.73) POLBAKR1C3CNR2MAPTNPC1
SCHEMBL30724575 0.73 AKR1C3 (0.45) POLBPIK3CAPIK3CDPIK3CBAKR1C3
SCHEMBL27251926 0.73 PIK3CD (0.46) POLBPIK3CAPIK3CDPIK3CBPIK3CG
SCHEMBL20504089 0.73 PIK3CA (0.48) PIK3CAPIK3CDPIK3CBPIK3CGAKR1C3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4436577-A1 TABLET FORMULATIONS OF RBP4 INHIBITORS AND METHODS OF USE Belite Bio, Inc (US) 2024-10-02 EP disclosed
WO-2023097221-A1 TABLET FORMULATIONS OF RBP4 INHIBITORS AND METHODS OF USE BELITE BIO, INC (US) 2023-06-01 WO disclosed